Pharmacological and expression profile of the prostaglandin I2 receptor in the rat craniovascular system

Activation of the trigeminal nerve terminals around cerebral and meningeal arteries is thought to be an important patho-mechanism in migraine. Vasodilatation of the cranial arteries may also play a role in increasing nociception. Prostaglandin I2 (PGI2) is capable of inducing a headache in healthy volunteers, a response that is likely to be mediated by the prostaglandin I2 receptor (IP). This study investigates the functional and molecular characteristics of the IP receptor in the rat craniovascular system. In the closed cranial window model, iloprost, an IP receptor agonist, dilated the rat middle meningeal artery (MMA) (Emax = 170% ± 16%; pED50 = 6.5 ± 0.2) but not the rat cerebral artery (CA) in vivo. The specific antagonist of the IP receptor, CAY10441, significantly blocked the iloprost-induced response dose-dependently, with the highest dose attenuating iloprost (1 μg kg− 1) induced dilatations by 70% (p < 0.05). CAY10441 did not have any effect on the prostaglandin E2-induced vasodilatory response, thus suggesting no interaction with EP2 and EP4 receptors. IP receptor mRNA transcripts and protein were present in meningeal as well as in cerebral rat vasculature, and localized the IP receptor protein to the smooth vasculature of the cranial arteries (MMA, MCA and basilar artery). Together, these results demonstrate that the IP receptor mediates the dilatory effect of PGI2 in the cranial vasculature in rats. Antagonism of this receptor might be of therapeutic relevance in acute migraine treatment.

Figure optionsDownload as PowerPoint slide